Wenisch C, Parschalk B, Schönthal E, Graninger W, Looareesuwan S, Rumpold H
Department of Infectious Diseases, University Hospital of Vienna, Austria.
Clin Immunol Immunopathol. 1996 Apr;79(1):15-9. doi: 10.1006/clin.1996.0045.
We determined serum levels of the carboxy-terminal-cross-linked telopeptide and carboxy-terminal propeptide of type I collagen (ICTP and PICP) in 24 patients with acute complicated Plasmodium falciparum malaria prior to and 7, 14, 21, and 28 days after therapy by radioimmunoassay in Bangkok, Thailand. Elevated levels of ICTP were observed in patients (mean +/- SD concentration 16.7 +/- 5.8 ng/ml), compared with normal controls (3.1 +/- 1.3 ng/ml), during the acute phase of the disease. In contrast, serum concentrations PICP were not different between patients and controls (168 +/- 63 and 144 +/- 57 ng/ml, respectively). After therapy serum ICTP concentrations decreased but remained elevated even 28 days after the malaria attack (10.3 +/- 2.9 ng/ml). These findings suggest an increased production or release of ICTP in P. falciparum malaria, which could implicate an alteration of extracellular matrix during P. falciparum malaria.
我们在泰国曼谷采用放射免疫分析法,测定了24例急性复杂性恶性疟原虫疟疾患者在治疗前以及治疗后第7、14、21和28天的血清I型胶原羧基末端交联肽和羧基末端前肽(ICTP和PICP)水平。在疾病急性期,患者的ICTP水平升高(平均±标准差浓度为16.7±5.8 ng/ml),而正常对照组为(3.1±1.3 ng/ml)。相比之下,患者和对照组的血清PICP浓度无差异(分别为168±63和144±57 ng/ml)。治疗后血清ICTP浓度下降,但即使在疟疾发作后28天仍高于正常水平(10.3±2.9 ng/ml)。这些发现表明,恶性疟原虫疟疾中ICTP的产生或释放增加,这可能意味着恶性疟原虫疟疾期间细胞外基质发生了改变。